| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.089 | 0.09 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.09 | 0.09 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.09 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.091 | 0.09 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |